TriSalus Life Sciences (TLSI) Capital Expenditures Growth (1y) (2023 - 2026)

TriSalus Life Sciences (TLSI) Capital Expenditures Growth (1y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -17.56%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 34.96%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -6.72%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 15.89%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -43.42%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -11.95%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 27.22%
10 TriSalus Life Sciences 192.50 Mn 135.95 Mn 7.67 Mn -81.30%

Historic Data

Download Data
DateValue
Mar 31, 2026 -81.30%
Dec 31, 2025 -98.55%
Dec 31, 2024 -7.26%
Dec 31, 2023 82.35%